PJT
- Product code
- PJT
- Device name
- Continuous Glucose Monitor Secondary Display
- Device class
- Class 2
- 21 CFR
- 21 CFR 862.1350
- Medical specialty
- Clinical Chemistry
- Marketing pathway
- 510(K) Exempt
- 510(k) clearances (all years, FDA)
- 2 (all years; only the last 3 years are listed here)
FDA classification definition
The purpose of the continuous glucose monitor secondary display is to notify another person, the follower, of the patient's continuous glucose monitoring system sensor glucose information in real time. The secondary display is intended for providing secondary notification of a continuous glucose monitoring system and does not replace primary real time continuous glucose monitoring or standard home blood glucose monitoring
Official FDA classification page: PJT
Classification and pathway per current FDA publications. Data from openFDA (CC0).